RGD Reference Report - Exploration of Hepatoprotective Effect of Gentiopicroside on Alpha-Naphthylisothiocyanate-Induced Cholestatic Liver Injury in Rats by Comprehensive Proteomic and Metabolomic Signatures. - Rat Genome Database

Send us a Message
Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   
Search RGD Grant Resources Citing RGD About Us Contact Us
Genes Variants Community Projects QTLs Strains Markers Genome Information Ontologies Cell Lines References Download Submit Data
OntoMate (Literature Search) JBrowse (Genome Browser) Synteny Browser (VCMap) Variant Visualizer Multi-Ontology Enrichment (MOET) Gene-Ortholog Location Finder (GOLF) InterViewer (Protein-Protein Interactions) PhenoMiner (Quatitative Phenotypes) Gene Annotator OLGA (Gene List Generator) AllianceMine GViewer (Genome Viewer)
Aging & Age-Related Disease Cancer & Neoplastic Disease Cardiovascular Disease Coronavirus Disease Developmental Disease Diabetes Hematologic Disease Immune & Inflammatory Disease Infectious Disease Liver Disease Neurological Disease Obesity & Metabolic Syndrome Renal Disease Respiratory Disease Sensory Organ Disease
Find Models Genetic Models Autism Models Rat PhenoMiner (Quantitative Phenotypes) Chinchilla PhenoMiner Expected Ranges (Quantitative Phenotype) PhenoMiner Term Comparison Hybrid Rat Diversity Panel Phenotypes Phenotypes in Other Animal Models Animal Husbandry Strain Medical Records Phylogenetics Strain Availability Calendar Rats 101 Submissions Photo Archive
Pathways
Rat Community Forum Directory of Rat Laboratories Video Tutorials News RGD Publications RGD Presentations Archive Nomenclature Guidelines Resource Links Laboratory Resources Employment Resources
Advanced Search (OLGA)

Exploration of Hepatoprotective Effect of Gentiopicroside on Alpha-Naphthylisothiocyanate-Induced Cholestatic Liver Injury in Rats by Comprehensive Proteomic and Metabolomic Signatures.

Authors: Han, Han  Xu, Lili  Xiong, Kai  Zhang, Tong  Wang, Zhengtao 
Citation: Han H, etal., Cell Physiol Biochem. 2018;49(4):1304-1319. doi: 10.1159/000493409. Epub 2018 Sep 17.
RGD ID: 15045612
Pubmed: PMID:30223280   (View Abstract at PubMed)
DOI: DOI:10.1159/000493409   (Journal Full-text)


BACKGROUND/AIMS: Cholestasis is the major cause of the accumulation of bile acids and results in liver damage, fibrosis, and failure. A growing number of studies have shown that gentiopicroside is a promising prospect that may protect the liver. However, its therapeutic mechanism has not yet been clarified. This study aimed to explore the effect and mechanism of gentiopicroside in cholestasis induced by alpha-naphthylisothiocyanate.
METHODS: We performed isobaric tags for relative and absolute quantification-based quantitative proteomics and metabolomics using liquid chromatography quadruple time-of-fight mass spectrometry and identified the expression of 73 metabolites and 84 proteins associated with cholestasis-related dysfunctions in the metabolism of bile acids, fatty acids, and glycerophospholipids.
RESULTS: Integrated analyses of proteomic and metabonomic studies showed altered pathways in cholestasis-induced liver injury involving increased activity of farnesoid X receptor/retinoid X receptor, bile acid biosynthesis, and peroxisome proliferator-activated receptor-α/retinoid X receptor-α. Gentiopicroside could reverse these metabolite, protein, and blood biochemical indices, as well as alleviate liver damage. The progressive changes in the proteins and genes may be correlated with cholestasis and were confirmed by western blot and quantitative realtime polymerase chain reaction.
CONCLUSION: Gentiopicroside could be used to protect the liver in the presence of cholestasis.



RGD Manual Disease Annotations    Click to see Annotation Detail View

  
Object SymbolSpeciesTermQualifierEvidenceWithNotesSourceOriginal Reference(s)
ABCC4Humancholestasis treatmentISOAbcc4 (Rattus norvegicus) RGD 
ALDH1L1Humancholestasis treatmentISOAldh1l1 (Rattus norvegicus) RGD 
Abcc4Mousecholestasis treatmentISOAbcc4 (Rattus norvegicus) RGD 
Abcc4Ratcholestasis treatmentIEP  RGD 
Aldh1l1Mousecholestasis treatmentISOAldh1l1 (Rattus norvegicus) RGD 
Aldh1l1Ratcholestasis treatmentIEP  RGD 
NR1H4Humancholestasis treatmentISONr1h4 (Rattus norvegicus) RGD 
Nr1h4Ratcholestasis treatmentIEP  RGD 
Nr1h4Mousecholestasis treatmentISONr1h4 (Rattus norvegicus) RGD 

Gene-Chemical Interaction Annotations    Click to see Annotation Detail View

  
Object SymbolSpeciesTermQualifierEvidenceWithNotesSourceOriginal Reference(s)
ALDH1L1Human1-naphthyl isothiocyanate decreases expressionISOAldh1l1 (Rattus norvegicus)1-naphthyl isothiocyanate decreases expression of ALDH1L1 mRNA in rat liverRGD 
Aldh1l1Rat1-naphthyl isothiocyanate decreases expressionEXP 1-naphthyl isothiocyanate decreases expression of ALDH1L1 mRNA in rat liverRGD 
Aldh1l1Mouse1-naphthyl isothiocyanate decreases expressionISOAldh1l1 (Rattus norvegicus)1-naphthyl isothiocyanate decreases expression of ALDH1L1 mRNA in rat liverRGD 
NR1H4Human1-naphthyl isothiocyanate decreases expressionISONr1h4 (Rattus norvegicus)1-naphthyl isothiocyanate decreases expression of Nr1h4 mRNA in rat liverRGD 
Nr1h4Rat1-naphthyl isothiocyanate decreases expressionEXP 1-naphthyl isothiocyanate decreases expression of Nr1h4 mRNA in rat liverRGD 
Nr1h4Mouse1-naphthyl isothiocyanate decreases expressionISONr1h4 (Rattus norvegicus)1-naphthyl isothiocyanate decreases expression of Nr1h4 mRNA in rat liverRGD 
ABCC4HumanGentiopicrin multiple interactionsISOAbcc4 (Rattus norvegicus)Gentiopicrin reverses the interaction [1-naphthyl isothiocyanate decreases expression of MRP4 mRNA in rat liver]RGD 
Abcc4RatGentiopicrin multiple interactionsEXP Gentiopicrin reverses the interaction [1-naphthyl isothiocyanate decreases expression of MRP4 mRNA in rat liver]RGD 
Abcc4MouseGentiopicrin multiple interactionsISOAbcc4 (Rattus norvegicus)Gentiopicrin reverses the interaction [1-naphthyl isothiocyanate decreases expression of MRP4 mRNA in rat liver]RGD 
CYP7A1HumanGentiopicrin decreases expressionISOCyp7a1 (Rattus norvegicus)Gentiopicrin decreases expression of Cyp7a1 mRNA in rat ANIT induced cholestatic liverRGD 
Cyp7a1RatGentiopicrin decreases expressionEXP Gentiopicrin decreases expression of Cyp7a1 mRNA in rat ANIT induced cholestatic liverRGD 
Cyp7a1MouseGentiopicrin decreases expressionISOCyp7a1 (Rattus norvegicus)Gentiopicrin decreases expression of Cyp7a1 mRNA in rat ANIT induced cholestatic liverRGD 
NR1H4HumanGentiopicrin multiple interactionsISONr1h4 (Rattus norvegicus)Gentiopicrin reverses the reaction [1-naphthyl isothiocyanate decreases expression of Nr1h4 mRNA in rat liver]RGD 
Nr1h4RatGentiopicrin multiple interactionsEXP Gentiopicrin reverses the reaction [1-naphthyl isothiocyanate decreases expression of Nr1h4 mRNA in rat liver]RGD 
Nr1h4MouseGentiopicrin multiple interactionsISONr1h4 (Rattus norvegicus)Gentiopicrin reverses the reaction [1-naphthyl isothiocyanate decreases expression of Nr1h4 mRNA in rat liver]RGD 

Objects Annotated

Genes (Rattus norvegicus)
Abcc4  (ATP binding cassette subfamily C member 4)
Aldh1l1  (aldehyde dehydrogenase 1 family, member L1)
Cyp7a1  (cytochrome P450 family 7 subfamily A member 1)
Nr1h4  (nuclear receptor subfamily 1, group H, member 4)

Genes (Mus musculus)
Abcc4  (ATP-binding cassette, sub-family C member 4)
Aldh1l1  (aldehyde dehydrogenase 1 family, member L1)
Cyp7a1  (cytochrome P450, family 7, subfamily a, polypeptide 1)
Nr1h4  (nuclear receptor subfamily 1, group H, member 4)

Genes (Homo sapiens)
ABCC4  (ATP binding cassette subfamily C member 4 (PEL blood group))
ALDH1L1  (aldehyde dehydrogenase 1 family member L1)
CYP7A1  (cytochrome P450 family 7 subfamily A member 1)
NR1H4  (nuclear receptor subfamily 1 group H member 4)


Additional Information